A gas therapy system (1) has a flow line (3, 2), a coupler (6) to a gas source, and an aerosol generator (4) for aerosol delivery, and a patient interface such as a nasal interface (2). A controller (10) is configured to modulate gas flow and aerosol delivery in real time. The controller changes gas flow rate and dynamically reduces aerosol delivery during upper gas flow rates such as 60 LPM, and activates aerosol delivery during lower gas flow rates of for example 10 LPM. The control may also include sensors to detect breathing, so that there is a bias towards increased aerosol delivery during inhalation in addition to during lower level gas flow.

A nasal rinsing cap suitable for standard water bottle is disclosed. The body portion of the device can be attached to the top of the bottle. It has a cylindrical void matching the threaded portion of the bottle and a one-way fluid valve attached to another void extending from the cylindrical void and through the body portion. The body portion also includes a one-way air valve allowing the entry of air into the bottle. A top portion is removably or openably attached to the body portion. It has a tubular opening starting near the body portion and extending through the top portion. The top portion is configured so that it has a tip to be contacted with the user's nasal cavities. The top portion also has a pressure zone for closing the fluid valve by applying a pressure on it.

A nasal rinsing cap suitable for standard water bottle is disclosed. The body portion of the device can be attached to the top of the bottle. It has a cylindrical void matching the threaded portion of the bottle and a one-way fluid valve attached to another void extending from the cylindrical void and through the body portion. The body portion also includes a one-way air valve allowing the entry of air into the bottle. A top portion is removably or openably attached to the body portion. It has a tubular opening starting near the body portion and extending through the top portion. The top portion is configured so that it has a tip to be contacted with the user's nasal cavities. The top portion also has a pressure zone for closing the fluid valve by applying a pressure on it.

Disclosed herein are aspects of portable vaporizers to deliver aliquots of heated air to material in a unitary furnace. The furnace is multipurposed reducing heat loss, air leakage and delays in availability of air aliquots at the proper temperature for use. By dividing the unitary furnace with an air permeable divider and placing material in the chamber a controller selectively providing electrical power to a heating element configured to heat air in at least an upper region of the unitary furnace. Upon application of suction to the fluid passage heated air passes into the material and vaporizes organic oils in the material and said heating a volume of air inside a unitary furnace vaporized material can be withdrawn from the fluid passage.

Provided is pharmaceutical composition for intranasal delivery, wherein the pharmaceutical composition includes a therapeutically active ingredient including a CGRP inhibitor. Also provided is a method for delivering a CGRP inhibitor to a subject, wherein the method includes intranasally administering to the subject a composition including a therapeutically active component including a CGRP inhibitor.

A system and method for automatically delivering a substance to an animal or fish including a positioning system that positions each animal singularly and a sensor that detects the location of a predetermined targeted area on the animal. The system further includes a delivery device for delivering a substance to the targeted area. The position of the delivery device may be adjustable. The delivery device is in communication with the sensor. The delivery device adjusts its position in response to the data received from the sensor and delivers a substance to the targeted area.

A system and method for automatically delivering a substance to an animal or fish including a positioning system that positions each animal singularly and a sensor that detects the location of a predetermined targeted area on the animal. The system further includes a delivery device for delivering a substance to the targeted area. The position of the delivery device may be adjustable. The delivery device is in communication with the sensor. The delivery device adjusts its position in response to the data received from the sensor and delivers a substance to the targeted area.

Provided herein are dry powder formulations comprising epinephrine alone or in combination with at least one enabling agent suitable for nasal application. Also provided are unit dose forms and devices comprising such formulations and methods of using such formulations for the treatment of various conditions including anaphylaxis, anaphylactoid reaction, respiratory conditions, hemodynamic collapse, and for administration during cardiopulmonary arrest and other life-threatening conditions.

An assistance device for the use with a product dispensing device includes an engaging unit to the dispensing device, a locking unit for locking the dispensing device and configured to prevent or permit dispensing of the product, and a measurement unit for measuring a quantity of the product dispensed by the dispensing device. The locking unit remains unlocked for a predetermined period of time starting from a predetermined activation of the assistance device and then locks automatically at the end of the predetermined period. The locking unit locks automatically when a quantity of the product dispensed during the predetermined period reaches or exceeds a predetermined threshold.

A combination product comprising a dispensing head (10, 10′) mounted on a top of a container (20, 20′) containing a formulation for nasal administration, and a solidified skin-care balm (50) for application around the nose contained in a balm holder element (30, 30″) located on a bottom (24) of the container (20).